Zenas BioPharma (USA), LLC clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Orelabrutinib · Primary Progressive Multiple Sclerosis

   Trial sites expanded: 67 → 71 locations

   Zenas BioPharma (USA), LLC·Phase 3· NCT07067463· Registry history of NCT07067463 on ClinicalTrials.gov (opens the registry)

   Oct 20, 2026

2. Minor

   Orelabrutinib · Secondary Progressive Multiple Sclerosis

   Trial sites expanded: 49 → 52 locations

   And 1 more change in the last 30 days

   Zenas BioPharma (USA), LLC·Phase 3· NCT07299019· Registry history of NCT07299019 on ClinicalTrials.gov (opens the registry)

   Oct 7, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.